Genzyme Corporation (GENZ) Announces Multi-Year Multiple Sclerosis Research Collaboration With Leading Academic Medical Center
4/30/2014 10:49:22 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today the formation of a research collaboration with Cleveland Clinic focused on developing new therapeutic approaches to the treatment of MS.
Help employers find you! Check out all the jobs and post your resume.
comments powered by